Megakaryocytes transfer mitochondria to bone marrow mesenchymal stromal cells to lower platelet activation.
Ontology highlight
ABSTRACT: Newly produced platelets acquire a low activation state, but whether the megakaryocyte plays a role in this outcome has not been fully uncovered. Mesenchymal stem cells (MSCs) were previously shown to promote platelet production and lower platelet activation. We found that healthy megakaryocytes transfer mitochondria to MSCs, which is mediated by connexin 43 (Cx43) gap junctions on MSCs and leads to platelets at a low energetic state with increased LYN activation, characteristic of resting platelets with increased LYN activation, characteristic of resting platelets. On the contrary, MSCs have a limited ability to transfer mitochondria to megakaryocytes. Sickle cell disease (SCD) is characterized by hemolytic anemia and results in heightened platelet activation, contributing to numerous dis
SUBMITTER: Gao C
PROVIDER: S-EPMC11996913 | biostudies-literature | 2025 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA